Evidence map›Paper›PMID 26546573›Full record

ArticleJournal of the American Heart Association2015

Thiosulfate Mediates Cytoprotective Effects of Hydrogen Sulfide Against Neuronal Ischemia.

Eizo Marutani, Marina Yamada, Tomoaki Ida, Kentaro Tokuda, Kohei Ikeda, Shinichi Kai, Kazuhiro Shirozu, Kei Hayashida, Shizuko Kosugi, Kenjiro Hanaoka and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 1 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 1 synthesis or guideline pooled it, 104 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Development of an HInternational journal of molecular sciences · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. HScience advances · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Targeted HBiomaterials research · 2024
    Article
  19. Review
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Eizo MarutaniDepartment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA (E.M., M.Y., K.T., K.I., S.K., K.S., K.H., S.K., M.K., F.I.).
Marina YamadaDepartment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA (E.M., M.Y., K.T., K.I., S.K., K.S., K.H., S.K., M.K., F.I.) Shriners Hospitals for Children, Boston, MA (M.Y., M.K.).
Tomoaki IdaDepartment of Environmental Health Sciences and Molecular Toxicology, Tohoku University Graduate School of Medicine, Sendai, Japan (T.I., T.A.).
Kentaro TokudaDepartment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA (E.M., M.Y., K.T., K.I., S.K., K.S., K.H., S.K., M.K., F.I.).
Kohei IkedaDepartment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA (E.M., M.Y., K.T., K.I., S.K., K.S., K.H., S.K., M.K., F.I.).
Shinichi KaiDepartment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA (E.M., M.Y., K.T., K.I., S.K., K.S., K.H., S.K., M.K., F.I.).
Kazuhiro ShirozuDepartment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA (E.M., M.Y., K.T., K.I., S.K., K.S., K.H., S.K., M.K., F.I.).
Kei HayashidaDepartment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA (E.M., M.Y., K.T., K.I., S.K., K.S., K.H., S.K., M.K., F.I.).
Shizuko KosugiDepartment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA (E.M., M.Y., K.T., K.I., S.K., K.S., K.H., S.K., M.K., F.I.).
Kenjiro HanaokaGraduate School of Pharmaceutical Sciences, The University of Tokyo, Japan (K.H.).
Masao KanekiDepartment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA (E.M., M.Y., K.T., K.I., S.K., K.S., K.H., S.K., M.K., F.I.) Shriners Hospitals for Children, Boston, MA (M.Y., M.K.).
Takaaki AkaikeDepartment of Environmental Health Sciences and Molecular Toxicology, Tohoku University Graduate School of Medicine, Sendai, Japan (T.I., T.A.).
Fumito IchinoseDepartment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA (E.M., M.Y., K.T., K.I., S.K., K.S., K.H., S.K., M.K., F.I.).
Harvard University · USMassachusetts General Hospital · USTohoku University · JPShriners Hospitals for Children - Boston · USThe University of Tokyo · JP

Funding

IMPACT OF HYDROGEN SULFIDE ON OUTCOME OF CARDIAC ARREST AND CARDIOPULMONARY RESUSR01HL101930 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ICHINOSE, FUMITO · 2010 to 2014
$2.1M
NHLBI NIH HHS HL101930NHLBI NIH HHS R01 HL101930
6 · The paper itself

Abstract

backgroundHydrogen sulfide (H2S) exhibits protective effects in various disease models including cerebral ischemia-reperfusion (I/R) injury. Nonetheless, mechanisms and identity of molecules responsible for neuroprotective effects of H2S remain incompletely defined. In the current study, we observed that thiosulfate, an oxidation product of H2S, mediates protective effects of an H2S donor compound sodium sulfide (Na2S) against neuronal I/R injury. METHODS AND

resultsWe observed that thiosulfate in cell culture medium is not only required but also sufficient to mediate cytoprotective effects of Na2S against oxygen glucose deprivation and reoxygenation of human neuroblastoma cell line (SH-SY5Y) and murine primary cortical neurons. Systemic administration of sodium thiosulfate (STS) improved survival and neurological function of mice subjected to global cerebral I/R injury. Beneficial effects of STS, as well as Na2S, were associated with marked increase of thiosulfate, but not H2S, in plasma and brain tissues. These results suggest that thiosulfate is a circulating "carrier" molecule of beneficial effects of H2S. Protective effects of thiosulfate were associated with inhibition of caspase-3 activity by persulfidation at Cys163 in caspase-3. We discovered that an SLC13 family protein, sodium sulfate cotransporter 2 (SLC13A4, NaS-2), facilitates transport of thiosulfate, but not sulfide, across the cell membrane, regulating intracellular concentrations and thus mediating cytoprotective effects of Na2S and STS.

conclusionsThe protective effects of H2S are mediated by thiosulfate that is transported across cell membrane by NaS-2 and exerts antiapoptotic effects via persulfidation of caspase-3. Given the established safety track record, thiosulfate may be therapeutic against ischemic brain injury.

Indexed as

AnimalsAnion Transport ProteinsApoptosisBrain IschemiaCaspase 3Cell HypoxiaCell Line, TumorCytoprotectionDose-Response Relationship, DrugGestational AgeGlucoseHumansMiceMice, Inbred C57BLMitochondriaNeuronsAnion Transport ProteinsCASP3 protein, humanCasp3 protein, mouseCaspase 3GlucoseNeuroprotective AgentsSLC13A4 protein, humanSlc13a4 protein, mousesodium hydrogen sulfiteSulfate TransportersSulfitesSymportersThiosulfatesapoptosiscerebral ischemiahydrogen sulfidesulfidationthiosulfate

Identifiers

PMID26546573
PMCPMC4845224
OpenAlexW2231256722

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.